Headlines & Links
Teva is managing inventory and can provide product from their emergency supply. Orders for Proglycem can be made during regular business hours (8am to 5pm Eastern, Monday through Friday) by calling Customer Service at 800-545-8800. Emergency requests can be made after hours by calling 800-795-2652
rate this
Published: about 2 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
CHICAGO (Reuters) - Eating a half serving a day of soy-based foods could be enough to significantly lower a man's sperm count, U.S. researchers said on Wednesday.
rate this
Published: about 14 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
CHICAGO (Reuters) - A growing number of older U.S. children are being diagnosed with attention deficit hyperactivity disorder, while diagnoses among younger children have held steady, government researchers said on Wednesday.
rate this
Published: about 15 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
NEW YORK (Reuters Health) - Girls and young women who devote much time to the Internet, get too little sleep or regularly drink alcohol are more likely than their peers to put on excess weight, a new study suggests.
rate this
Published: about 17 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
NEW YORK (Reuters Health) - While psychological factors increase the risk of developing coronary heart disease, they do not affect inflammation, a factor also associated with the development of coronary heart disease, according to findings published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology.
rate this
Published: about 17 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
BOSTON (Reuters) - British researchers have located a gene responsible for muscle pain or weakness experienced by some people taking statin drugs to fight "bad" cholesterol, they reported on Wednesday.
rate this
Published: about 18 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
WASHINGTON (Reuters) - Cholesterol-fighting statin drugs, already known to help ward off heart attack and stroke, may help people who have received a kidney transplant live longer, researchers said on Wednesday.
rate this
Published: about 18 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
WASHINGTON (Reuters) - Cyclist and testicular cancer survivor Lance Armstrong joined forces with four former U.S. surgeons general on Wednesday to urge Americans to do more to prevent cancer and get recommended screening tests.
rate this
Published: about 18 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
WASHINGTON (Reuters) - Cancer findings in a new study of cholesterol drug Vytorin are "likely to be an anomaly" unrelated to the drug, makers Merck & Co and Schering-Plough Corp said in a letter to doctors.
rate this
Published: about 18 hours ago
rate this
Published: about 18 hours ago
rate this
Published: about 19 hours ago
rate this
Published: about 19 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
NEW YORK (Reuters Health) - Novice teenage smokers often make repeated attempts to quit smoking soon after they start, but most are unsuccessful, according to research funded by the Canadian Cancer Society.
rate this
Published: about 19 hours ago
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited
WASHINGTON (Reuters) - Essential health care workers would be immunized first if a flu pandemic broke out in the United States, the government said on Wednesday.
rate this
Published: about 20 hours ago
Despite stagnant erythropoietin (EPO) sales, four new EPO products were introduced in Europe during the last year, but the pipeline shifts from biosimilar based approaches to next generation erythropoiesis stimulating agents (ESA) BARCELONA, Spain,...
rate this
Published: about 23 hours ago
rate this
Published: 1 day ago
LONDON, 23 July 2008-GlaxoSmithKline (GSK) today announced a transformational agreement to significantly extend its pharmaceutical portfolio in emerging markets. The licensing collaboration between GSK and South African based pharmaceuticals...
rate this
Published: 1 day ago
LONDON, July 2008 - Dan Troy has been appointed as Senior Vice President and General Counsel for GlaxoSmithKline (GSK), and will join the company on 2nd September 2008. Dan was formerly Chief Counsel for the US Food and Drug...
rate this
Published: 1 day ago
- Grow a diversified global business - Deliver more products of value - Simplify GSK's operating model LONDON, 23 July 2008-In a presentation to investors today, Andrew Witty, CEO GlaxoSmithKline, set out three new strategic priorities that...
rate this
Published: 1 day ago
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--July 23, 2008--Bristol-Myers Squibb Company and AstraZeneca today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) on June 30th and validation of a...
rate this
Published: 1 day ago
Question Whether FDA Knowingly Allowed Potentially Unsafe & Ineffective Drugs Into U.S. Market WASHINGTON, July 22, 2008 - Reps. John D. Dingell (D-MI), Chairman of the Committee on Energy and Commerce, and Bart Stupak (D-MI),...
rate this
Published: 1 day ago
BRISBANE, Australia, 23 July 2008. Following a thorough review that concluded late yesterday, the Board of Progen Pharmaceuticals Limited (ASX:PGL; NASDAQ:PGLA) today announced that it had discontinued the PI-88 phase 3 study in liver cancer. Progen...
rate this
Published: 1 day ago
EAST WINDSOR, N.J.--(BUSINESS WIRE)--July 22, 2008 - NexMed, Inc. today announced the receipt of a non approvable letter from the U.S. Food and Drug Administration (FDA) in response to its New Drug Application (NDA) for its topical treatment for...
rate this
Published: 1 day ago
NEW YORK--(BUSINESS WIRE)--Jul 23, 2008 - Pfizer Inc (NYSE: PFE): -0- ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------...
rate this
Published: 1 day ago
- 2008 Second Quarter Worldwide Net Revenue Increased 5% to $5.9 Billion and Reported Diluted Earnings per Share Decreased 5% to $0.83. Diluted Earnings per Share, before Certain Significant Items, Increased 1% to $0.91 MADISON, N.J., July 23, 2008...
rate this
Published: 1 day ago
| Related Articles |
Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health.
Bull NYU Hosp Jt Dis. 2008;66(2):155-65
Authors: Pincus T
Quantitative clinical assessment measures and indices have been developed for many rheumatic diseases. However, these measures and indices generally are used only in clinical trials and other clinical research, as they are too complex for collection and calculation at a usual clinical visit. The only quantitative measures available in most rheumatology patient care are laboratory tests, which often give false positive and false negative results and may not be available at the time of a patient visit. The most feasible method to collect quantitative data in routine care involves patient self-report questionnaires, completed while waiting to see the physician and reviewed by the clinician at the time of the visit. A multidimensional health assessment questionnaire (MDHAQ) provides a useful one-page questionnaire to assess the three self-report Data Set measures-physical function, pain, patient global estimate, as well as review of systems, recent medical history, fatigue, and demographic data. An index of the three Core Data Set measures, routine assessment of patient index data (RAPID3), can be used to guide "tight control" of inflammation, analogous to a disease activity score (DAS28). RAPID3 can be scored in fewer than 10 seconds and is informative in patients with all rheumatic diseases. It is suggested that the infrastructure of all rheumatology care settings include a patient questionnaire for each patient, with all diagnoses, at each visit to improve quantitative guidance of clinical decisions, documentation of status and improvements, and patient outcomes.
PMID: 18537789 [PubMed - in process]
(Source: Bulletin of the NYU Hospital for Joint Diseases)rate this
Published: 1 day ago
BASEL, Switzerland and TORONTO, July 23, 2008 /PRNewswire-FirstCall/ - Roche and ARIUS Research Inc. today announced that the two companies have signed a definitive agreement for Roche to acquire ARIUS in an all-cash transaction at a price of...
rate this
Published: 1 day ago
| Related Articles |
Pediatric experience with the VentrAssist LVAD.
Ann Thorac Surg. 2008 Aug;86(2):622-6
Authors: Ruygrok PN, Esmore DS, Alison PM, Finucane KA, McGuinness SP, McGeorge AD, Negri J, Jones K, Gibbs HC
PURPOSE: The purpose of this study is to describe the first experience of implanting a new left ventricular assist device in pediatric patients with end-stage heart failure. DESCRIPTION: In two recent prospective, international, multicenter clinical trials, three children (aged = 16 years) were implanted successfully with the VentrAssist (Ventracor Limited, Chatswood, Australia), a relatively small, novel, continuous flow, third-generation left ventricular assist device. EVALUATION: Despite the patients' disease severity (each child was in extremis at the time of implantation), VentrAssist (Ventracor Limited) implantation enabled each patient to be discharged home from the hospital. All patients survived for more than 1 year. One patient was successfully transplanted and another was bridged to an adequate degree of recovery; unfortunately, the third patient died on postoperative day 375 while waiting for a suitable donor heart. Consistent with the complications associated with left ventricular assist devices in adults, the main complications in these pediatric patients were infection and throm